Загрузка...
Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is heralded as the next big global epidemic. Hepatic de novo lipogenesis (DNL), the synthesis of new fatty acids from non-lipid sources, is thought to play a pivotal role in the development of NAFLD. While there is currently no NAFLD-specific therapeutic age...
Сохранить в:
| Опубликовано в: : | Lipids Health Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5027077/ https://ncbi.nlm.nih.gov/pubmed/27640119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-016-0321-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|